Rare diseases
Investigational molecules
Locations
Forskargatan 20c, 151 36 Sodertalje, Sweden
Anocca AB’s clinical research is centered on pancreatic ductal adenocarcinoma, with attention to advanced disease settings including metastatic and locally advanced disease. The sponsor’s trial activity reflects a focused interest in tumor immunology and precision oncology for patients with limited treatment options.
The research landscape includes matching patients to HLA-restricted and KRAS-targeted cellular therapies, highlighting a therapeutic focus on antigen-specific treatment strategies in gastrointestinal oncology.
Anocca AB runs clinical trials in conditions such as Pancreatic carcinoma metastatic, Adenocarcinoma pancreas, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
